A5024599463- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Cardiac Arrhythmias and Treatments
- Heart Failure Treatment and Management
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Cardiac electrophysiology and arrhythmias
- Cardiac pacing and defibrillation studies
- Blood Pressure and Hypertension Studies
- Cardiac Health and Mental Health
- Lipoproteins and Cardiovascular Health
- Antiplatelet Therapy and Cardiovascular Diseases
- ECG Monitoring and Analysis
- Venous Thromboembolism Diagnosis and Management
- Coronary Interventions and Diagnostics
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Systems, Economic Evaluations, Quality of Life
- Diabetes Treatment and Management
- Heart Rate Variability and Autonomic Control
- Cardiac Structural Anomalies and Repair
- Non-Invasive Vital Sign Monitoring
- Cardiovascular Effects of Exercise
- Cardiac, Anesthesia and Surgical Outcomes
- Pharmaceutical Economics and Policy
- Cardiovascular and exercise physiology
Hospital Universitari Sant Joan D'Alacant
2015-2024
Centro de Investigación en Red en Enfermedades Cardiovasculares
2017-2024
Universitat de Miguel Hernández d'Elx
2013-2024
Centro de Investigación Biomédica en Red
2017-2024
Hospital Clínica Benidorm
2023-2024
Centre for Biomedical Network Research on Rare Diseases
2021-2024
Hospital Universitario Infanta Sofía
2024
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
2021-2023
Laboratoire Lorrain de Recherche en Informatique et ses Applications
2023
Uppsala University
2021-2022
Increasing the patient's heart rate (HR) has emerged as a therapeutic option in patients with failure preserved ejection fraction (HFpEF). However, evidence is conflicting, and profile of who benefit most from this strategy remains unclear.
Introduction The potential impact of targeting different components an adverse lipid profile in populations with multiple cardiovascular risk factors is not completely clear. This study aims to assess the association between standard all-cause mortality and hospitalization due events a high-risk population. Methods prospective registry included high adults over 30 years old free disease (2008–2012). Diagnosis hypertension, dyslipidemia or diabetes mellitus was inclusion criterion. Lipid...
AimElevated brain natriuretic peptide (BNP) and tumour marker antigen carbohydrate 125 (CA125) levels have shown to be associated with higher risk for adverse outcomes in patients acute heart failure (AHF). Nevertheless, no attempt has been made explore the utility of combining these two biomarkers. We sought assess whether CA125 adds prognostic value BNP predicting 6-month all-cause mortality AHF.
Background: Erectile dysfunction (ED) is a multifactorial disease related to age, vascular disease, psychological disorders, or medical treatments. Beta‐blockade agents are the recommended treatment for hypertensive patients with some specific organ damage but have been outlined as one of leading causes drug‐related ED, although differences between beta‐blockade not assessed. Methods: Cross‐sectional and observational study male subjects treated any agent at least 6 months. ED was assessed...
ABSTRACT Background Vitamin K antagonists ( VKA ) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence anticoagulant control in patients under treatment prevention stroke for atrial fibrillation AF ). Hypothesis Control with is inadequate high percentage AF. Methods Patients were prospectively recruited this observational registry. The sample comprised 948 patients. estimated time spent range TTR was...
To assess whether circulating levels of carbohydrate antigen 125 (CA125) predict subsequent 6-month all-cause mortality in patients after the index hospitalisation for acute heart failure (HF).Prospective cohort study at a single teaching centre Spain.529 consecutive with HF admitted university were analysed. In addition to traditional clinical information, CA125 (U/ml) was measured during early course hospitalisation. The independent association between baseline and assessed Cox regression...
Background The optimal dosage of cryotherapy during cryoballoon ablation pulmonary veins is still unclear. This trial tested the noninferiority a novel, individualized, cryotherapy-dosing strategy for each vein. Methods and Results prospective, randomized, multicenter, study included 140 patients with paroxysmal atrial fibrillation, which was refractory to antiarrhythmic drugs. Patients were randomly assigned conventional 180-second applications per vein bonus freeze (control group, n=70) or...
This study aims to assess the current state of childhood overweight and obesity in Spain, its relationship with socioeconomic status health-related behaviors. Population-based cross-sectional observational study, based on 2017 National Health Survey minors Spain. included all children surveyed who were aged 1–14 years. Childhood was estimated from z-score body mass index. The 4882 years (mean 7.5). prevalence 18.6% (95% confidence interval [CI] 18.5–18.7), while 13.5% CI 13.4–13.6)...